A Double-Blind, Randomized, Controlled, Multicenter Safety and Immunogenicity Study of a Refrigerator-Stable Formulation of Zostavax

The vaccine Zostavax has been shown to prevent herpes zoster (HZ) and postherpetic neuralgia and is recommended for individuals ≥60 years of age. This study compared the safety and the immunogenicity of a refrigerator-stable formulation (Zostavax refrigerated) with those of the current formulation (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gilderman, Larry I., Lawless, James F., Nolen, Thomas M., Sterling, Tina, Rutledge, Ruth Z., Fernsler, Doreen A., Azrolan, Neal, Sutradhar, Santosh C., Wang, William W., Chan, Ivan S. F., Schlienger, Katia, Schödel, Florian, Silber, Jeffrey L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology (ASM) 2008
Schlagworte:
Vaccine Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2238040/
https://ncbi.nlm.nih.gov/pubmed/18077611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00310-07
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge